TIPIFARNIB IN RELAPSED OR REFRACTORY ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA (AITL) AND CXCL12+ PERIPHERAL T-CELL LYMPHOMA (PTCL): PRELIMINARY RESULTS FROM AN OPEN-LABEL, PHASE 2 STUDY

EHA Library, Dr. Thomas Witzig, 267452

A COMBINATORIAL RECEPTOR STRATEGY TO IMPROVE MULTIPLE MYELOMA THERAPY WITH CHIMERIC ANTIGEN RECEPTOR-ENGINEERED T LYMPHOCYTES

EHA Library, Afroditi Katsarou, 267494

EFFICACY OF DARATUMUMAB + BORTEZOMIB/THALIDOMIDE/DEXAMETHASONE (D-VTD) IN TRANSPLANT-ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA BASED ON MINIMAL RESIDUAL DISEASE STATUS: ANALYSIS OF CASSIOPEIA

EHA Library, Hervé Avet-Loiseau, 267457

DEVELOPMENT OF HUMANIZED MOUSE MODEL FOR STUDYING MOTHER TO CHILD HTLV-1 TRANSMISSION AND PREVENTION WITH HTLV-1 ANTIBODY TREATMENT.

EHA Library, Takuo Mizukami, 267490

RESULTS OF ASTRAL-1 STUDY, A PHASE 3 RANDOMIZED TRIAL OF GUADECITABINE (G) VS TREATMENT CHOICE (TC) IN TREATMENT NAÏVE ACUTE MYELOID LEUKEMIA (TN-AML) NOT ELIGIBLE FOR INTENSIVE CHEMOTHERAPY (IC)

EHA Library, Pierre Fenaux, 267462

THE COMPLEXITY OF GENOTYPE-PHENOTYPE CORRELATIONS IN HEREDITARY SPHEROCYTOSIS: A COHORT OF 95 PATIENTS.

EHA Library, A.J. Van Vuren, 267485

COMBINATION OF ASCIMINIB PLUS NILOTINIB (NIL) OR DASATINIB (DAS) IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA (CML): RESULTS FROM A PHASE 1 STUDY

EHA Library, Michael J. Mauro, 267467

VALIDATION OF A NOVEL MECHANISM OF ACTION FOR TREATMENT OF CCR7+ HEMATOLOGICAL MALIGNANCIES WITH FIRST-IN-CLASS ANTIBODY CAP-100

EHA Library, Carlos Cuesta-Mateos, 267480

APOPTOTIC MESENCHYMAL STROMAL CELLS INDUCE PROSTAGLANDIN E2 IN MONOCYTES: IMPLICATIONS FOR THE MONITORING OF MESENCHYMAL STROMAL CELL ACTIVITY

EHA Library, Tik Shing Cheung, 267476

EMERGING CLINICAL ACTIVITY OF REGN1979, AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY (AB), IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) B-CELL NON-HODGKIN LYMPHOMA (B-NHL)

EHA Library, Rajat Bannerji, 267451

EFFICACY OF QUADRUPLET KCRD (CARFILZOMIB, CYCLOPHOSPHAMIDE, LENALIDOMIDE AND DEXAMETHASONE) INDUCTION FOR NEWLY DIAGNOSED MYELOMA PATIENTS: ANALYSIS OF THE MYELOMA XI STUDY BY MOLECULAR RISK

EHA Library, Charlotte PAWLYN, 267456

THE FIRST-IN-CLASS ANTI-CD47 ANTIBODY HU5F9-G4 IS ACTIVE AND WELL TOLERATED ALONE OR IN COMBINATION WITH AZACITIDINE IN AML AND MDS PATIENTS: INITIAL PHASE 1B RESULTS

EHA Library, David Sallman, 267461

PRECLINICAL EVALUATION OF THE PRESERVATION OF RED BLOOD CELL CONCENTRATES IN HYPOXIA BY HYPOXIC STORAGE TECHNOLOGY FOR TRANSFUSION IN SICKLE CELL DISEASE.

EHA Library, Laura Bencheikh, 267489

COMBINATION THERAPY USING ASCIMINIB PLUS IMATINIB (IMA) IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA (CML): RESULTS FROM A PHASE 1 STUDY

EHA Library, Jorge Cortes, 267466

COMBINED GENE PANEL SEQUENCING AND EKTACYTOMETRY - THE NEXT GENERATION OF RED CELL DIAGNOSTICS

EHA Library, Nicholas Parkin, 267484

INTESTINAL STEM CELL DAMAGE IN GRAFT-VERSUS-HOST DISEASE IS PRIMARILY CAUSED BY T-CELL DERIVED INTERFERON-GAMMA

EHA Library, Suze Jansen, 267475

SUCCESSFUL TREATMENT OF INTESTINAL GRAFT-VERSUS-HOST DISEASE WITH FECAL MICROBIOTA TRANSPLANTATION

EHA Library, Yannouck van Lier, 267474

SYNTHETIC LETHAL EFFECTS OF DUAL BCR AND PARP INHIBITION IN PROLIFERATIVE DEL(11Q) CLL CELLS IN THE PRESENCE OF STROMAL STIMULATION

EHA Library, Miguel Quijada-Álamo, 267479

DISSECTING THE ROLE OF CXCL4 IN PRIMARY MYELOFIBROSIS

EHA Library, Hélène Gleitz, 267472

EVIDENCE BASED USE OF ERYTRHOPOIETIN IN PATIENTS WITH AUTOIMMUNE HEMOLYTIC ANEMIA: A MULTICENTER INTERNATIONAL STUDY

EHA Library, Bruno Fattizzo, 267483

OPTIMIZATION OF TKI TREATMENT IN ELDERLY PATIENTS WITH PH+ CHRONIC MYELOID LEUKEMIA AND STABLE MR3.0 OR MR4.0: 1ST YEAR RESULTS OF THE ITALIAN MULTICENTRIC PHASE-III RANDOMIZED OPTKIMA STUDY

EHA Library, Michele Malagola, 267465

LONG TERM INHIBITION OF COMPLEMENT C1S IN PATIENTS WITH COLD AGGLUTININ DISEASE: RESULTS FROM A NAMED PATIENT PROGRAM

EHA Library, Georg Gelbenegger, 267488

SAFETY AND CLINICAL ACTIVITY OF AMV564, A CD33/CD3 T-CELL ENGAGER, IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML): UPDATED RESULTS FROM THE PHASE 1 FIRST-IN-HUMAN TRIAL

EHA Library, Peter Westervelt, 267460

A NEW MEMBRANE-BOUND IL-21/4-1BBL-EXPANDED NK PRODUCT EXHIBITS ACTIVITY AGAINST ACUTE MYELOID LEUKEMIA ACTIVITY IN VIVO

EHA Library, Xiangyu Zhao, 267493

CARFILZOMIB LENALIDOMIDE DEXAMETHASONE (KRD) WITH OR WITHOUT TRANSPLANTATION IN NEWLY DIAGNOSED MYELOMA (FORTE TRIAL): EFFICACY ACCORDING TO RISK STATUS

EHA Library, Francesca Gay, 267455

THE FIRST-IN-CLASS ANTI-CD47 ANTIBODY HU5F9-G4 WITH RITUXIMAB INDUCES DURABLE RESPONSES IN RELAPSED/REFRACTORY DLBCL AND INDOLENT LYMPHOMA: INTERIM PHASE 1B/2 RESULTS

EHA Library, Mark Roschewski, 267450

INHIBITION OF C3 WITH APL-2 CONTROLS HAEMOLYSIS AND INCREASES HAEMOGLOBIN LEVELS IN SUBJECTS WITH AUTOIMMUNE HAEMOLYTIC ANAEMIA (AIHA)

EHA Library, Bruno Fattizzo, 267482

POT1 MUTATIONS DRIVE GENOMIC INSTABILITY AND CONFER SYNTHETIC LETHALITY WITH G-QUADRUPLEX STABILIZING AGENTS IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Saskia Rudat, 267478

NEW WHOLE GENOME ASSOCIATION SCANNING APPROACH FOR THE DISCOVERY OF HLA CLASS I-RESTRICTED MINOR HISTOCOMPATIBILITY ANTIGENS

EHA Library, Kyra Fuchs, 267473

CLASSIFICATION OF MYELOPROLIFERATIVE NEOPLASMS BASED ON DEEP LEARNING ALGORITHMS AND MOLECULAR GENETIC MARKERS SUPPORT DISTINCTION OF CML, PV, ET, AND PMF

EHA Library, Manja Meggendorfer, 267471

THE FUNCTIONAL RESPONSE OF IRON-RECYCLING AND INFECTION CONTROL-SPECIALIZED MACROPHAGES IS IMPAIRED BY TRANSFUSIONS AND AMELIORATED BY IRON CHELATION

EHA Library, Francesca Vinchi, 267487

PREGNANCY OUTCOME IN FEMALE PATIENTS WITH CHRONIC MYELOID LEUKEMIA WORLDWIDE: ANALYSIS OF 305 CASES OF THE EUROPEAN LEUKEMIA NET REGISTRY

EHA Library, Ekaterina Chelysheva, 267464

AXL-RTK INHIBITION DIRECTS THE FUNCTIONAL PHENOTYPE OF CHIMERIC ANTIGEN RECEPTOR T CELLS

EHA Library, Reona Sakemura, 267492

GILTERITINIB SIGNIFICANTLY PROLONGS OVERALL SURVIVAL IN PATIENTS WITH FLT3-MUTATED (FLT3MUT+) RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML): RESULTS FROM THE PHASE 3 ADMIRAL TRIAL

EHA Library, Alexander Perl, 267459

CURATIVE STRATEGY (GEM-CESAR) FOR HIGH-RISK SMOLDERING MYELOMA: CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE (KRD) AS INDUCTION FOLLOWED BY HDT-ASCT, CONSOLIDATION WITH KRD AND MAINTENANCE WITH RD

EHA Library, María-Victoria Mateos, 267454

PHASE 1/2 TRIAL OF ACALABRUTINIB PLUS PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Dr. Thomas Witzig, 267449

ITP during Pregnancy

EHA Library, Nichola Cooper, 274169

MRD in MM

EHA Library, Stefania Oliva, 274166

EHA Education and Mentoring Awards 2019

EHA Library, Irene Roberts, 277209

EHA Education and Mentoring Awards 2019

EHA Library, Shaun McCann, 277208

Iron homeostasis in host defense and inflammation

EHA Library, Elizabeta Nemeth, 273539

Jean Bernard Lifetime Achievement Award Lecture

EHA Library, Wim Fibbe, 273538

Neuronal regulation of normal and malignant bone morrow niches

EHA Library, Simón Méndez-Ferrer, 273537

ALTERATION OF IRON HOMEOSTASIS IN A MOUSE MODEL OF LIVER-STAGE PLASMODIUM INFECTION

EHA Library, Francesca Vinchi, 267439

TARGETING ABERRANT DNA METHYLATION AS A NOVEL AND UNIFORM THERAPEUTIC STRATEGY FOR THE TREATMENT OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND LYMPHOMA

EHA Library, Morgan Thénoz, 267443

NIVOLUMAB AND BRENTUXIMAB VEDOTIN-BASED, RESPONSE-ADAPTED TREATMENT IN PRIMARY REFRACTORY AND IN PEDIATRIC PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA IN CHECKMATE 744

EHA Library, Thierry LeBlanc, 267405

CLINICAL RESPONSES AND PHARMACOKINETICS OF FULLY HUMAN BCMA TARGETING CAR T CELL THERAPY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Chunrui Li, 267410

CHANGE IN CLONE SIZE DOES NOT PREDICT RISK OF MAJOR ADVERSE VASCULAR EVENTS: RESULTS FROM THE INTERNATIONAL PNH REGISTRY

EHA Library, Philippe Gustovic, 267448

A PHASE 2A STUDY OF THE LSD1 INHIBITOR IMG-7289 FOR THE TREATMENT OF MYELOFIBROSIS

EHA Library, Kristen Pettit, 267415

AZACITIDINE AND ASCORBATE INHIBIT COMPETITIVE OUTGROWTH OF HUMAN TET2-MUTANT HSPCS IN A XENOGRAFT MODEL OF PRE-LEUKEMIA

EHA Library, Yusuke Nakauchi, 267419

DYNAMIC GENETIC EVOLUTION IN MYELODYSPLASTIC SYNDROME AND THE CLINICAL IMPLICATIONS

EHA Library, Yu Jen Lin, 267424

HNRNP K LEVELS PREDICT FOR POOR CLINICAL RESPONSES IN DLBCL AND REPRESENT A NOVEL THERAPEUTIC TARGET

EHA Library, Sean Post, 267429

A FULLY HUMAN BISPECIFIC ANTIBODY FUNCTIONALLY RESCUES FACTOR VIII DEFICIENCY EX VIVO

EHA Library, Wei Wang, 267434

GENOME-WIDE CRISPR-CAS9 SCREEN REVEALS SYNTHETIC LETHALITY OF WNT PATHWAY ACTIVATION AND ASPARAGINASE IN DRUG-RESISTANT ACUTE LEUKEMIAS

EHA Library, Laura Hinze, 267332

TNF-Α BLOCKADE CORRECTS THE MONOCYTE/MACROPHAGE IMBALANCE IN PRIMARY IMMUNE THROMBOCYTOPENIA (ITP)

EHA Library, Yajing Zhao, 267432

FRONTLINE BRENTUXIMAB VEDOTIN WITH CHEMOTHERAPY FOR STAGE 3/4 CLASSICAL HODGKIN LYMPHOMA: 3-YEAR UPDATE OF THE ECHELON-1 STUDY

EHA Library, Andrea Gallamini, 267403

NIVOLUMAB PLUS DOXORUBICIN, VINBLASTINE AND DACARBAZINE FOR NEWLY DIAGNOSED ADVANCED-STAGE CLASSICAL HODGKIN LYMPHOMA: 2-YEAR EXTENDED FOLLOW-UP FROM COHORT D OF THE PHASE 2 CHECKMATE 205 STUDY

EHA Library, Eva Domingo Domènech, 267404

ONE-YEAR EFFICACY OF RAVULIZUMAB (ALXN1210) IN ADULT PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA NAIVE TO COMPLEMENT INHIBITORS

EHA Library, Hubert Schrezenmeier, 267446

PREDICTED NEOANTIGENS PROVIDE PROGNOSTIC INSIGHT IN DLBCL

EHA Library, Sally Trabucco, 267428

KDM5 INHIBITION OFFERS A NOVEL THERAPEUTIC STRATEGY FOR THE TREATMENT OF KMT2D MUTANT LYMPHOMAS

EHA Library, James Heward, 267427

EVALUATION OF AMG 420, AN ANTI-BCMA BISPECIFIC T-CELL ENGAGER (BITE®) IMMUNOTHERAPY, IN R/R MULTIPLE MYELOMA (MM) PATIENTS: UPDATED RESULTS OF A FIRST-IN-HUMAN (FIH) PHASE 1 DOSE ESCALATION STUDY

EHA Library, Max Topp, 267408

IMPROVED EFFICACY AND SAFETY OF A DUAL-TARGET CAR-T CELL THERAPY TARGETING BCMA AND CD38 FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM A PHASE I STUDY

EHA Library, Heng Mei, 267409

TCD IMPLEMENTATION RATES AND RESULTS IN THE MODERN ERA OF SICKLE CELL ANEMIA: RESULTS FROM THE DISPLACE STUDY

EHA Library, Julie Kanter, 267438

IMPACT OF 1ST LINE TREATMENT ON OVERALL SURVIVAL IN 1.633 PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA - A MULTINATIONAL COLLABORATIVE EFFORT COORDINATED BY THE AGMT STUDY GROUP

EHA Library, Lisa Pleyer, 267423

PHASE II STUDY OF ORAL RIGOSERTIB COMBINED WITH AZACITIDINE IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES (MDS)

EHA Library, Michael E. Petrone, 267422

A PHASE 2 OPEN-LABEL PROOF OF CONCEPT STUDY OF THE ORAL, SMALL MOLECULE FACTOR D INHIBITOR, ACH-4471, IN UNTREATED PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)

EHA Library, Peter Browett, 267447

AVAPRITINIB, A POTENT AND SELECTIVE INHIBITOR OF KIT D816V, INDUCES COMPLETE AND DURABLE RESPONSES IN PATIENTS (PTS) WITH ADVANCED SYSTEMIC MASTOCYTOSIS (ADVSM)

EHA Library, Deepti Radia, 267413

CPI-0610, A BROMODOMAIN AND EXTRATERMINAL DOMAIN (BET) INHIBITOR, REDUCES PRO-INFLAMMATORY CYTOKINES, BONE MARROW FIBROSIS AND THE NUMBER OF TRANSFUSIONS IN MYELOFIBROSIS PATIENTS

EHA Library, Ronald Hoffman, 267414

MASS CYTOMETRY REVEAL EARLY SIGNALING RESPONSES TO INDUCTION THERAPY IN IMMUNOPHENOTYPICALLY DEFINED LEUKEMIC CELL SUBSETS THAT PREDICT SURVIVAL IN AML

EHA Library, Benedicte Tislevoll, 267418

SAFETY AND EFFICACY OF AN ANTI-FCRN ANTIBODY, ROZANOLIXIZUMAB, IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA: INTERIM RESULTS OF A PHASE II, MULTIPLE-DOSE STUDY

EHA Library, Tadeusz Robak, 267433

IMR-687, A HIGHLY SELECTIVE PHOSPHODIESTERASE 9 INHIBITOR (PDE9I), DEMONSTRATES PRELIMINARY EVIDENCE OF ACTIVITY ON RED AND WHITE CELL BIOMARKERS IN A PH-2A INTERIM ANALYSIS

EHA Library, Biree Andemariam, 267437

SUCCESSOR: A MULTICENTER RETROSPECTIVE NONINTERVENTIONAL FOLLOW-UP STUDY IN PATIENTS WITH SICKLE CELL PAIN CRISES WHO PREVIOUSLY PARTICIPATED IN THE SUSTAIN TRIAL IN THE UNITED STATES

EHA Library, Darla Liles, 267436

SOTATERCEPT (ACE-011) IN SUBJECTS WITH MPN-ASSOCIATED MYELOFIBROSIS AND ANEMIA

EHA Library, Prithviraj Bose, 267412

TRANSFUSION DEPENDENCY IS ASSOCIATED WITH PRESENCE OF TOXIC IRON SPECIES AND INFERIOR SURVIVAL IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES

EHA Library, Marlijn Hoeks, 267421

THE PROLIFERATIVE HISTORY SHAPES THE DNA METHYLOME OF B-CELL TUMORS AND PREDICTS CLINICAL OUTCOME

EHA Library, Martí Duran-Ferrer, 267426

A PHASE 3 RANDOMIZED, OPEN-LABEL, MULTICENTER STUDY OF ISATUXIMAB, POMALIDOMIDE, AND LOW-DOSE DEXAMETHASONE VS POMALIDOMIDE AND LOW-DOSE DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

EHA Library, Paul Richardson, 267407

ALLELIC POLYMORPHISM OF PLATELET GLYCOPROTEIN GENES GPIA AND GPIIB AS A POSSIBLE PREDICTIVE MARKER OF RESPONSE TO THERAPY IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA

EHA Library, Irina Zotova, 267431

THE ROLE OF GATA2 IN HSC GENERATION THROUGH ENDOTHELIAL-TO-HEMATOPOIETIC TRANSITION.

EHA Library, Cansu Koyunlar, 267445

SUZ12 INACTIVATION COOPERATES WITH JAK3 MUTANT SIGNALING TO DRIVE T-ALL DEVELOPMENT

EHA Library, Michael Broux, 267441

PET AFTER 2 CYCLES OF ABVD IN PATIENTS WITH EARLY-STAGE FAVORABLE HODGKIN LYMPHOMA TREATED WITHIN THE PHASE 3 GHSG HD16 STUDY

EHA Library, Michael Fuchs, 267402

PEGCRISANTASPASE AND VENETOCLAX COMBINATION IS HIGHLY EFFECTIVE AGAINST ACUTE MYELOID LEUKEMIA (AML), MECHANISTICALLY DRIVEN SYNERGISM BETWEEN GLUTAMINE DEPLETION AND BCL-2 INHIBITION

EHA Library, Ashkan Emadi, 267417

Do our expectations for CAR T cell therapy outweigh the facts? Patient Perspectives on CAR-T gaps and challenges

EHA Library, Brian Koffman, 274193

Microbiota and GvHD development: a double edge sword

EHA Library, Ernst Holler, 274192

The role of epigenomics to diagnose and estimate prognosis in lymphoid neoplasms

EHA Library, Iñaki Martin-Subero, 274191

The role of epigenomics to diagnose and estimate prognosis in lymphoid neoplasms

EHA Library, Iñaki Martin-Subero, 274243

THE SINGLE-CELL ATLAS OF DRIVER MUTATIONS IN AML

EHA Library, Kiyomi Morita, 267416

TREATMENT WITH IMETELSTAT PROVIDES DURABLE TRANSFUSION INDEPENDENCE (TI) IN HEAVILY TRANSFUSED NON-DEL(5Q) LOWER RISK MDS (LR-MDS) RELAPSED/REFRACTORY (R/R) TO ERYTHROPOIESIS STIMULATING AGENTS (ESAS)

EHA Library, Pierre Fenaux, 267420

A RANDOMIZED, DOUBLE BLIND PHASE 2 STUDY OF 3 DIFFERENT DOSES OF PRM-151 IN PATIENTS WITH MYELOFIBROSIS WHO WERE PREVIOUSLY TREATED WITH OR INELIGIBLE FOR RUXOLITINIB

EHA Library, Srdan Verstovsek, 267411

MODELING MANTLE CELL LYMPHOMA IN MICE

EHA Library, Tim Pieters, 267425

RANDOMIZED, OPEN-LABEL, NON-INFERIORITY, PHASE 3 STUDY OF SUBCUTANEOUS (SC) VERSUS INTRAVENOUS (IV) DARATUMUMAB (DARA) ADMINISTRATION IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA: COLUMBA

EHA Library, María-Victoria Mateos, 267406

IN VIVO SELECTION FOR CORRECTED BETA-GLOBIN ALLELES AFTER CRISPR/CAS9 EDITING IN HUMAN SICKLE HEMATOPOIETIC STEM CELLS ENHANCES THERAPEUTIC POTENTIAL

EHA Library, Mark WALTERS, 267435

DISTINCT AND COMMON DEREGULATED PATHWAYS IN RUNX1, GATA1 AND GFI1B ASSOCIATED BLEEDING DISORDERS

EHA Library, Maaike van Bergen, 267430

LOSS OF THE F-BOX PROTEIN NIPA CAUSES BONE MARROW FAILURE

EHA Library, Stefanie Kreutmair, 267444

PRIMARY THERAPY AND SURVIVAL AMONG ADULT PATIENTS WITH NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA (NLPHL): A POPULATION-BASED ANALYSIS IN THE NETHERLANDS, 1993-2016

EHA Library, Hidde Posthuma, 267401

THE NUCLEOTIDE KINASE NADK CONSTITUTES A METABOLIC VULNERABILITY OF NOTCH1-DRIVEN T-ALL

EHA Library, Etienne De Braekeleer, 267440

NGS technologies in AML: Time to use in clinical care?

EHA Library, Torsten Haferlach, 274187

Impact of social stigma on coping with SCD

EHA Library, Kofi Anie, 274186

Pathophysiology and therapeutic targets in acquired aplastic anemia: Inferences from immunosuppression and stem cell stimulation

EHA Library, Neal Young, 274183

Iron homeostasis in host defense and inflammation

EHA Library, Elizabeta Nemeth, 274182

Neuronal regulation of normal and malignant BM niches

EHA Library, Simón Méndez-Ferrer, 274181